期刊文献+

HPV16E6的表达与宫颈鳞癌发病的相关性研究 被引量:3

Study on the Correlation between Expression of HPV16E6 and Cervical Squamous Carcinoma
下载PDF
导出
摘要 目的研究人乳头瘤病毒16E6(HPV16E6)蛋白在宫颈鳞癌中的表达及意义。方法应用免疫组织化学链霉菌抗生物素蛋白-过氧化物酶连接法观察40例宫颈鳞癌、30例宫颈上皮内瘤样病变(C IN)和30例正常宫颈组织中HPV16 E6的表达。结果 HPV16E6在正常宫颈组织、C IN和宫颈鳞癌组织中的阳性表达率分别为:13.3%、53.3%、82.5%,各组间表达率比较,差异有统计学意义(P<0.01)。HPV16E6蛋白阳性表达在宫颈鳞癌病理分级、临床分期中的比较,差异无统计学意义(P>0.05)。结论 HPV16E6在宫颈鳞癌的发生发展中起重要作用,可能是宫颈鳞癌发病机制之一。对HPV16E6蛋白的致病机制进一步研究,有助于揭示宫颈癌的发病机制,可能用于临床宫颈癌诊断、预防和基因治疗。 Objective To study human papillomavirus16 E6(HPV16E6) expression and their significance in cervical squamous carcinomas(CSC).Methods IImmunohistochemical staining for HPV16E6 was performed by SP methods in 40 cases of CSC,30 cases of cervical intraepithelial neoplasias(CIN),and 30 cases of normal cervical epithelium.Results he expression of HPV16E6 in 13.3% of normal cervical epithelium,53.3% of CINs,and 82.5% of the CSC were found,which were significantly statistically different(P0.001).No statistical difference of the expression of HPV16E6 in different degrees of and clinical stages of CSC were observed(P0.05).Conclusion The high detection rate of HPV16E6 in the CSC indicates it plays an important role in CSC development,which might be one of the pathogenesises(or might be the causes of CSC).The results of the study of HPV16E6′s biological effects on CSC′ development and its interaction in CSC can help reveal the pathogenesis of CSC.The factor could be the potential CSC clinical diagnosis indicator and useful in CSC′s precaution and genetic therapy.
作者 李惠新 雷静
出处 《医学综述》 2011年第16期2507-2508,共2页 Medical Recapitulate
基金 甘肃省教育厅项目(02B3-13)
关键词 宫颈肿瘤 人乳头瘤病毒16 免疫组织化学 Uterine cervical neoplasms Human papillomavirus 16 Immunohistochemistry
  • 引文网络
  • 相关文献

参考文献8

  • 1魏丽惠.宫颈病变诊断和治疗中的过度与不足[J].中国妇产科临床杂志,2009,10(2):83-84. 被引量:33
  • 2Zur-Hausen H.Papillomaviruses and cancer:from basic studies to clinical application[J].Nat Rev Cancer,2002,2(5):342-350.
  • 3Sjoeborg KD,Tropé A,Lie AK,et al.HPV genotype distribution according to severity of cervical neoplasia[J].Gynecol Oncol,2010,118(1):29-34.
  • 4Quint KD,de Koning MN,van Doorn LJ,et al.HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix[J].Gynecol Oncol,2010,117(2):297-301.
  • 5Giarnieri E,Zanesi N,Bottoni A,et al.Oncosuppressor proteins of fragile sites are reduced in cervical cancer[J].Cancer Lett,2010,289(1):40-45.
  • 6李亚松,石松生,杨卫忠.p73蛋白在脑膜瘤表达的意义[J].福建医科大学学报,2004,38(2):164-165. 被引量:7
  • 7Reuschenbach M,Clad A,von Knebel Doeberitz C,et al.Performance of p16INK4a-cytology,HPV mRNA,and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results[J].Gynecol Oncol,2010,119(1):98-105.
  • 8Coquillard G,Palao B,Patterson BK.Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA[J].Gynecol Oncol,2011,120(1):89-93.

二级参考文献19

  • 1Solomon D,Davey D,Kurman R,et al.The 2001 Bethesda System:terminology for reporting results of cervical cytology.JAMA,2002,287:2114-2119.
  • 2Thomas C,Wright Jr.L,Massad S,et al.2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests.American Society for Colposcopy and Cervical Pathology Journal of Lower Genital Tract Disease,2007,11:201-222.
  • 3Thomas C,Wright Jr.L,Massad S,et al.Management of Women With Cervical Intraepithelial Neoplasia or Adenocarcinoma In Situ.American Society for Colposcopy and Cervical Pathology Journal of Lower Genital Tract Disease,2007,11:223-239.
  • 4Cuzick J,Arbyn M,Sankaranarayanan R,et al.Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.Vaccine,2008,26 (Suppl 10):K29-41.
  • 5Naucler P,Ryd W,Tǒrnberg S,et,al.Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.J Natl Cancer Inst,2009,101:88-99.
  • 6Kjaer S,Hφgdall E,Frederiksen K,et al.The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive,cytologically normal women over a 10-year period.Cancer Res,2006,66:10630-10636.
  • 7Cuzick J,Clavel C,Petry KU,et al.Overview of the European and North American studies on HPV testing in primary cervical cancer screening.Int J Cancer,2006,119:1095-1101.
  • 8Caraway NP,Khanna A,Dawlett M,et al.Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.Gynecol Oncol,2008,110:37-42.
  • 9Rouzier R.Management of CIN1.J Gynecol Obstet Biol Reprod (Paris),2008,37(Suppl 1):S114-120.
  • 10DeLaurenzi V,Catani MV,Terrionni A,et al.Additional complexity in p73:induction by mitogens in lymphoid cells and identification of two newsplicing variants gamma and delta[J].Cell Death Differ,1999,6(5):389-390.

共引文献37

同被引文献30

  • 1拉莱.苏祖克,彭玉华,周康,房新志,王莉.新疆不同民族子宫颈癌发病趋势分析[J].新疆医科大学学报,2006,29(7):569-571. 被引量:81
  • 2卞美璐.WHO(2006年)宫颈癌综合防治实践指南简介[J].中国实用妇科与产科杂志,2007,23(7):557-560. 被引量:106
  • 3Cuschieri KS,Cubie HA,Whitley MW,et al.Multiple high risk HPVinfection are common in cervical neoplasia and young women in acervical screening population[J].J Clin Pathol,2004,57(1):68-72.
  • 4Zur HH. Papillomaviruses causing cancer:evasion from host- cell control in early events in carcinogenesis [J]. J Natl Cancer Inst, 2000,92 (9) : 690-698.
  • 5Scheffner M,Werness BA,Huibregtse JM,et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 [J]. Cell, 1990,63 (6) :1129-1136.
  • 6Boyer SN,Wazer DE,Band V. E7 protein of human papil- loma virus-16 induces degradation of retinoblastoma pro- tein through the ubiquitin-proteasome pathway [J]. Cancer Res, 1996,56 (20) : 4620-4624.
  • 7Bodily J,Laimins LA. Persistence of human papillomavirus infection:keys to malignant progression [J]. Trends Micro- biol, 2011,19(1) :33-39.
  • 8Kuhling H,Alm P,Olsson H,et al.Expression of cyclins E,A,and B,and prognosis in lymph node-negative breast cancer[J].J Pathol,2003;199(4):424-31.
  • 9Martin CM,Astbury K,O'Leary JJ.Molecular profiling of cervical neoplasia[J].Expert Rev Mol Diagn,2006;6(2):217-29.
  • 10Davy CE,Jackson DJ,Raj K,et al.Human papillomavirus type 16 E1E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes[J].J Virol,2005;79(7):3998-4011.

引证文献3

二级引证文献27

;
使用帮助 返回顶部